SK112996A3 - Firoblast growth factor-10 - Google Patents

Firoblast growth factor-10 Download PDF

Info

Publication number
SK112996A3
SK112996A3 SK1129-96A SK112996A SK112996A3 SK 112996 A3 SK112996 A3 SK 112996A3 SK 112996 A SK112996 A SK 112996A SK 112996 A3 SK112996 A3 SK 112996A3
Authority
SK
Slovakia
Prior art keywords
polypeptide
fgf
dna
polynucleotide
sequence
Prior art date
Application number
SK1129-96A
Other languages
English (en)
Slovak (sk)
Inventor
Jing-Shan Hu
Jeannine Gocayne
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of SK112996A3 publication Critical patent/SK112996A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factors [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
SK1129-96A 1994-03-08 1995-03-08 Firoblast growth factor-10 SK112996A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/207,412 US5817485A (en) 1994-03-08 1994-03-08 Nucleic acids and cells for recombinant production of fibroblast growth factor-10
PCT/US1995/002950 WO1995024414A1 (en) 1994-03-08 1995-03-08 Fibroblast growth factor-10

Publications (1)

Publication Number Publication Date
SK112996A3 true SK112996A3 (en) 1997-01-08

Family

ID=22770445

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1129-96A SK112996A3 (en) 1994-03-08 1995-03-08 Firoblast growth factor-10

Country Status (21)

Country Link
US (2) US5817485A (de)
EP (2) EP0750628B1 (de)
JP (2) JPH09510103A (de)
CN (1) CN1150804A (de)
AT (1) ATE251637T1 (de)
AU (1) AU1986195A (de)
CA (1) CA2183961A1 (de)
CZ (1) CZ260696A3 (de)
DE (1) DE69531892T2 (de)
DK (1) DK0750628T3 (de)
ES (1) ES2208676T3 (de)
FI (1) FI963475A (de)
HU (1) HUT77578A (de)
IL (1) IL112878A0 (de)
MX (1) MX9603897A (de)
NO (1) NO963728L (de)
PL (1) PL316202A1 (de)
PT (1) PT750628E (de)
SK (1) SK112996A3 (de)
WO (1) WO1995024414A1 (de)
ZA (1) ZA951886B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040157A (en) 1994-03-08 2000-03-21 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US7186688B1 (en) 1994-03-08 2007-03-06 Human Genome Sciences, Inc. Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
DE69434538T2 (de) 1994-03-08 2006-08-10 Human Genome Sciences, Inc. Vaskulärer endothelialer Wachstumsfaktor 2
US6608182B1 (en) 1994-03-08 2003-08-19 Human Genome Sciences, Inc. Human vascular endothelial growth factor 2
US6734285B2 (en) 1994-03-08 2004-05-11 Human Genome Sciences, Inc. Vascular endothelial growth factor 2 proteins and compositions
US7153827B1 (en) 1994-03-08 2006-12-26 Human Genome Sciences, Inc. Vascular endothelial growth factor 2 and methods of use
US5932540A (en) 1994-03-08 1999-08-03 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US7109308B1 (en) 1994-03-08 2006-09-19 Human Genome Sciences, Inc. Antibodies to human vascular endothelial growth factor 2
US5693775A (en) * 1995-05-12 1997-12-02 The Johns Hopkins University School Of Medicine Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use
WO1996039509A1 (en) * 1995-06-05 1996-12-12 Human Genome Sciences, Inc. Fibroblast growth factor 15
US5773252A (en) 1995-06-05 1998-06-30 Human Genome Sciences, Inc. Fibroblast growth factor 15
US6020189A (en) * 1996-08-30 2000-02-01 The Johns Hopkins University School Of Medicine Fibroblast growth factor homologous factors (FHFs) and methods of use
US6812327B1 (en) 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
US8212004B2 (en) 1999-03-02 2012-07-03 Human Genome Sciences, Inc. Neutrokine-alpha fusion proteins
JPH10279501A (ja) * 1997-02-10 1998-10-20 Rohto Pharmaceut Co Ltd 育毛剤
US6335317B1 (en) * 1998-04-10 2002-01-01 Emory University Use of gut-trophic growth factors to improve oxidative status
US7223724B1 (en) 1999-02-08 2007-05-29 Human Genome Sciences, Inc. Use of vascular endothelial growth factor to treat photoreceptor cells
WO2000071152A1 (en) * 1999-05-21 2000-11-30 Human Genome Sciences, Inc. Fibroblast growth factor 10
NZ522700A (en) 2000-06-16 2006-02-24 Human Genome Sciences Inc Antibodies that immunospecifically bind to blys
US7879328B2 (en) 2000-06-16 2011-02-01 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to B lymphocyte stimulator
AU8473401A (en) 2000-08-04 2002-02-18 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
WO2002016411A2 (en) 2000-08-18 2002-02-28 Human Genome Sciences, Inc. Binding polypeptides and methods based thereon
CA2444632A1 (en) 2001-04-13 2002-10-24 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US7402312B2 (en) 2001-04-13 2008-07-22 Human Genome Sciences, Inc. Antibodies to vascular endothelial growth factor 2 (VEGF-2)
US20060183712A1 (en) * 2005-02-17 2006-08-17 The Texas A&M University System Affinity purified heparin/heparan sulfate for controlling the biological activity of the FGF receptor
US9168286B2 (en) 2005-10-13 2015-10-27 Human Genome Sciences, Inc. Methods and compositions for use in treatment of patients with autoantibody positive disease
WO2007123765A2 (en) 2006-03-31 2007-11-01 Human Genome Sciences Inc. Neutrokine-alpha and neutrokine-alpha splice variant
KR101187871B1 (ko) 2009-09-23 2012-10-05 (주)케어젠 Ｆｇｆ１０－유래 펩타이드 및 그의 용도
WO2012071516A2 (en) * 2010-11-23 2012-05-31 Kci Licensing, Inc. Devices and methods for the diagnosis and treatment of wounds using biomarkers
CN103169658A (zh) * 2012-10-26 2013-06-26 温州医学院 成纤维细胞生长因子-10脂质体制备及在毛发再生中的应用
EP4183796A1 (de) 2021-11-19 2023-05-24 Enantis s.r.o. Thermostabiles fgf10-polypeptid oder fragment davon, verwendung davon

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155214A (en) * 1984-03-05 1992-10-13 The Salk Institute For Biological Studies Basic fibroblast growth factor
US4868113A (en) * 1986-03-03 1989-09-19 Rorer Biotechnology, Inc. Recombinant DNA vector encoding human endothelial cell growth factor
JP3303211B2 (ja) * 1991-04-26 2002-07-15 武田薬品工業株式会社 ｂＦＧＦムテインおよびその製造法
AU4995193A (en) * 1992-08-04 1994-03-03 Regeneron Pharmaceuticals, Inc. Method of enhancing differentiation and survival of neuronal precursor cells

Also Published As

Publication number Publication date
NO963728L (no) 1996-11-07
CN1150804A (zh) 1997-05-28
EP0750628A1 (de) 1997-01-02
JP2002335982A (ja) 2002-11-26
CA2183961A1 (en) 1995-09-14
JPH09510103A (ja) 1997-10-14
DK0750628T3 (da) 2004-02-02
ZA951886B (en) 1996-09-09
ES2208676T3 (es) 2004-06-16
FI963475A0 (fi) 1996-09-05
EP0750628A4 (de) 1997-06-11
IL112878A0 (en) 1995-06-29
PL316202A1 (en) 1996-12-23
NO963728D0 (no) 1996-09-06
DE69531892T2 (de) 2004-07-22
HUT77578A (hu) 1998-06-29
WO1995024414A1 (en) 1995-09-14
US5817485A (en) 1998-10-06
MX9603897A (es) 1997-07-31
HU9602434D0 (en) 1996-11-28
ATE251637T1 (de) 2003-10-15
US20020034787A1 (en) 2002-03-21
AU1986195A (en) 1995-09-25
FI963475A (fi) 1996-11-05
EP0750628B1 (de) 2003-10-08
PT750628E (pt) 2004-03-31
CZ260696A3 (en) 1997-05-14
DE69531892D1 (de) 2003-11-13
EP1380594A1 (de) 2004-01-14

Similar Documents

Publication Publication Date Title
SK112996A3 (en) Firoblast growth factor-10
JP4439490B2 (ja) 血管内皮細胞増殖因子２
US7741055B2 (en) Prostatic growth factor
US6521227B1 (en) Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides
NZ269871A (en) Haemopoietic maturation factor and coding sequences
JP2002300893A (ja) ヒト成長ホルモン
WO1996018730A1 (en) Prostatic growth factor
US5858705A (en) Polynucleotides encoding human DNA ligase III and methods of using these polynucleotides
US6639052B1 (en) Human ADA2 polypeptides
US6358702B1 (en) Polynucleotides encoding human Hox C10
US6573360B1 (en) Human ABH
KR19990008319A (ko) 섬유아세포 성장 인자 15
JPH10201491A (ja) タンパク質ホスファターゼ１結合タンパク質ｒ５
MXPA96003897A (en) Factor 10 of fibroblas growth
WO1996011259A1 (en) TGF-β1, ACTIVIN RECEPTORS 1 AND 3
JPH1132782A (ja) Ｙｎｌ０７５ｗ／ｈｔｘｆｔ１９ポリヌクレオチドおよびポリペプチド
JPH1132783A (ja) Ｈｆｉｚｇ５３ポリヌクレオチドおよびポリペプチド
JP2002325590A (ja) ケラチノサイト増殖因子−２
AU2005200547A1 (en) Vascular Endothelial Growth Factor 2
CA2430223A1 (en) Keratinocyte growth factor-2
MXPA97008493A (en) Factor 15 of fibroblas growth
AU1247800A (en) Fibroblast growth factor 15